S. Gaur

发表

Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.

A. Lawrence, R. Gillespie, C. Dourish, 2008, Bioorganic & medicinal chemistry letters.

Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines.

R. Gillespie, C. Dourish, D. S. Williamson, 2008, Bioorganic & medicinal chemistry letters.

3,5-Disubstituted-4-hydroxyphenyls Linked to 3-Hydroxy-2-methyl- 4(1H)-pyridinone: Potent Inhibitors of Lipid Peroxidation and Cell Toxicity

A. Palmer, C. Malcolm, K. Benwell, 2000 .

Prodrug and covalent linker strategies for the solubilization of dual-action antioxidants/iron chelators.

J. Spencer, C. Dawson, D. Bebbington, 2002, Bioorganic & medicinal chemistry letters.

Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.

A. Knight, R. Gillespie, D. Surry, 2009, Journal of medicinal chemistry.

Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.

A. Lawrence, R. Gillespie, S. Ward, 2008, Bioorganic & medicinal chemistry letters.

Antagonists of the human A(2A) receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides.

R. Gillespie, A. Jordan, J. Lerpiniere, 2009, Bioorganic & medicinal chemistry letters.

Indoline derivatives as 5-HT(2C) receptor agonists.

G. Kennett, C. Dourish, D. Adams, 2004, Bioorganic & medicinal chemistry letters.

Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides.

R. Gillespie, D. S. Williamson, P. Jackson, 2009, Bioorganic & medicinal chemistry.